This inventor holds 19 USPTO granted patents and 8 published patent applications and 9 EPO patents, primarily in Chlamydia Research. Top assignees: Glaxosmithkline Biologicals Sa, Novartis Vaccines & Diagnostics, Gmbh, Novartis Vaccines and Diagnostics Srl. Active years: 1992-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:




Years Active: 1992-2016
Areas of Expertise:
Title: Giulio Ratti: Innovator in Vaccine Development
Introduction
Giulio Ratti is a prominent inventor based in Siena, Italy. He has made significant contributions to the field of vaccine development, holding a total of 19 patents. His work focuses on proteins that are predicted to be useful antigens for vaccines and diagnostics.
Latest Patents
Among his latest patents, Giulio Ratti has developed inventions that provide proteins, including the amino acid sequences and the corresponding nucleotide sequences. These proteins are anticipated to play a crucial role in the development of effective vaccines and diagnostic tools.
Career Highlights
Giulio Ratti has worked with notable companies in the pharmaceutical industry, including GlaxoSmithKline Biologicals and Novartis Vaccines and Diagnostics. His experience in these organizations has allowed him to contribute to groundbreaking advancements in vaccine technology.
Collaborations
Throughout his career, Giulio has collaborated with esteemed colleagues such as Guido Grandi and Vega Masignani. These partnerships have further enhanced his research and innovation in the field.
Conclusion
Giulio Ratti's contributions to vaccine development and his extensive patent portfolio highlight his role as a key innovator in the industry. His work continues to impact the field of immunology and diagnostics significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile